Added to YB: 2018-06-20
Pitch date: 2018-06-20
TSRO [bearish]
Tesaro, Inc.
-62.67%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Tesaro, Inc., an oncology-focused biopharmaceutical company that identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.
Market Cap
$4.1B
Pitch Price
$46.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-6.32
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
TESARO INC TSRO
A summary for this pitch has not been created yet.
Read full article (0 min)